Global life sciences company Pressure BioSciences (OTCQB:
PBIO) was recently highlighted in a release by The Ohio State University
detailing the university’s upcoming study regarding healthier food and beverage
options. Per the news release, a team of scientists from Ohio State’s
College of Food, Agricultural, and Environmental Sciences (“CFAES”) has been
awarded a four-year, $891,000 grant from the U.S. Department of Agriculture’s
(“USDA”) National Institute of Food and Agriculture. The main objective of the
grant is to develop an innovative manufacturing technology to preserve food and
beverages using wholesome, identifiable ingredients, no artificial
preservatives and reduced use of heat, by utilizing Ultra-Shear Technology
(“UST”). UST is an innovative method that enables beverage companies to
manufacture healthier beverages by reducing thermal exposure through the
combined application of elevated pressure, shear, and controlled times and
temperatures.
V.M. Dr. “Bala” Balasubramaniam, a CFAES professor of food
engineering, is leading the research project. Dr. Bala believes that UST also
holds the potential to be utilized by food manufacturers to ensure a healthier
processing of sauces, condiments and other foods. “Development of
cost-effective, next-generation, gentler industrial food manufacturing
technologies for the preservation of healthy beverages has now become a
critical need,” Dr. Balasubramaniam stated in the news release.
The CFAES research team will collaborate with scientists and
engineers at Pressure BioSciences during the project, including Edmund Ting, a
senior vice president at PBIO. Ting will lead the development of the laboratory
scale and pilot plant equipment that CFAES and the company’s researchers will
use in the research project. “It has been rewarding to see the significant
growth of high-pressure food and beverage processing over the last 25 years,”
PBIO senior vice president Edmund Ting stated in the news release. “I believe
UST has equal if not greater applications than high-pressure processing, both
within and outside the food and beverage industries.”
To view the full press release, visit http://ibn.fm/zS4fI
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. Our products are based on the unique
properties of both constant (i.e., static) and alternating (i.e., pressure
cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling
technology platform that uses alternating cycles of hydrostatic pressure
between ambient and ultra-high levels to safely and reproducibly control
bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our
primary focus is in the development of PCT-based products for biomarker and
target discovery, drug design and development, biotherapeutics characterization
and quality control, soil & plant biology, forensics, and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of our pressure-based technologies in the following areas: (1) the use of
our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into
the biologics contract research services sector, and (2) the use of our
recently-patented, scalable, high-efficiency, pressure-based Ultra Shear
Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise
immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality,
homogenized, extended shelf-life or room temperature stable low-acid liquid
foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
